Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension
- 9 December 2022
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 28 (3-4) , 432-446
Abstract
Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (CIH), is a common risk factor for pulmonary arterial hypertension (PAH). As a hypoxia-induced transcription factor, differentially expressed in chondrocytes (DEC1) negatively regulates the transcription of peroxisome proliferative activated receptor-γ (PPARγ), a recognized protective factor of PAH. However, whether and how DEC1 is associated with PAH pathogenesis remains unclear. In the present study, we found that DEC1 was increased in lungs and pulmonary arterial smooth muscle cells (PASMCs) of rat models of OSA-associated PAH. Oxidative indicators and inflammatory cytokines were also elevated in the blood of the rats. Similarly, hypoxia-treated PASMCs displayed enhanced DEC1 expression and reduced PPARγ expression in vitro. Functionally, DEC1 overexpression exacerbated reactive oxygen species (ROS) production and the expression of pro-inflammatory cytokines (such as TNFα, IL-1β, IL-6, and MCP-1) in PASMCs. Conversely, shRNA knockdown of Dec1 increased PPARγ expression but attenuated hypoxia-induced oxidative stress and inflammatory responses in PASMCs. Additionally, DEC1 overexpression promoted PASMC proliferation, which was drastically attenuated by a PPARγ agonist rosiglitazone. Collectively, these results suggest that hypoxia-induced DEC1 inhibits PPARγ, and that this is a predominant mechanism underpinning oxidative stress and inflammatory responses in PASMCs during PAH. DEC1 could be used as a potential target to treat PAH.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020QH155, ZR2021MH189)
This publication has 57 references indexed in Scilit:
- Differentiated Embryo Chondrocyte 1 (DEC1) Represses PPARγ2 Gene through Interacting with CCAAT/Enhancer Binding Protein β (C/EBPβ)Molecules and Cells, 2012
- Human Primary Lung Endothelial Cells in CultureAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Rosiglitazone attenuates hypoxia‐induced pulmonary arterial hypertension in ratsRespirology, 2010
- Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanismNucleic Acids Research, 2008
- Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivoAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Stra13 is induced by genotoxic stress and regulates ionizing‐radiation‐induced apoptosisEMBO Reports, 2007
- Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13Oncogene, 2006
- DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancerThe Journal of Pathology, 2003
- Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profilingOncogene, 2000
- Molecular Characterization of the Novel Basic Helix–Loop–Helix Protein DEC1 Expressed in Differentiated Human Embryo ChondrocytesBiochemical and Biophysical Research Communications, 1997